CLNN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.70%

Insider Buying (Last 12 Months): $4,354,343.48

Insider Selling (Last 12 Months): $520,414.87

Clene Insider Trading History Chart

Clene Share Price & Price History

^$1.59

▼ -0.03 (-1.85%)

As of 02/3/2023 01:00 AM ET

Days: 30 | 90 | 365

“Future Fuel” will unleash $11 trillion wave of wealth

From Wall Street Watch Dogs | Ad

The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…

Click here for the full story

Clene Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/2/2022	David J Matlin	Director	Buy	2,871,287	$1.01	$2,899,999.87	5,293,684
8/17/2022	John Henry Stevens	Director	Buy	47,662	$3.85	$183,498.70	335,234
7/18/2022	Robert Dee Etherington	CEO	Sell	23,483	$4.72	$110,839.76	56,593
6/17/2022	David J Matlin	Director	Buy	74,610	$2.51	$187,271.10	2,422,397
6/15/2022	Alison Mosca	Director	Buy	5,000	$2.62	$13,100.00	39,476
6/13/2022	David J Matlin	Director	Buy	55,000	$3.06	$168,300.00	2,176,776
6/6/2022	David J Matlin	Director	Buy	50,670	$2.57	$130,221.90	2,121,776
6/3/2022	David J Matlin	Director	Buy	10,000	$2.46	$24,600.00	2,071,106
5/27/2022	David J Matlin	Director	Buy	35,000	$2.27	$79,450.00	2,061,106
5/16/2022	General Resonance Llc	Major Shareholder	Sell	181,818	$2.20	$399,999.60	15,560,212
5/16/2022	Jonathon Gay	Director	Buy	10,000	$2.08	$20,800.00	68,745
5/16/2022	Robert Glanzman	Insider	Sell	4,717	$2.03	$9,575.51	10,564
4/20/2022	David J Matlin	Director	Buy	132,891	$3.01	$400,001.91	1,844,288
3/28/2022	David J Matlin	Director	Buy	10,000	$3.10	$31,000.00
3/23/2022	David J Matlin	Director	Buy	20,000	$2.94	$58,800.00
3/21/2022	David J Matlin	Director	Buy	35,000	$2.90	$101,500.00
3/18/2022	David J Matlin	Director	Buy	20,000	$2.79	$55,800.00
2/1/2022	David J Matlin	Director	Buy	101,352	$2.96	$300,001.92
12/10/2021	David J Matlin	Director	Buy	15,000	$4.87	$73,050.00
12/8/2021	David J Matlin	Director	Buy	5,000	$4.93	$24,650.00
5/24/2021	David J. Matlin	Director	Buy	207,684	$9.63	$1,999,996.92	32,393

Know Your Profit Potential BEFORE You Trade!

From Tradewins | Ad

Click Here to Learn More

SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)

5.86% of Clene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Clene Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2022	Tang Capital Management LLC	1,100,000	$3.08M	0.4%	N/A	1.490%
11/15/2022	Two Sigma Investments LP	33,399	$94K	0.0%	N/A	0.045%
11/15/2022	Vanguard Group Inc.	931,613	$2.61M	0.0%	+14.7%	1.262%
11/15/2022	Kepos Capital LP	400,000	$1.12M	0.1%	-33.3%	0.542%
11/14/2022	Royal Bank of Canada	52,017	$0.15M	0.0%	N/A	0.070%
10/21/2022	Morgan Jess S & Co. Inc.	112,000	$0.31M	0.3%	+28.4%	0.176%
8/18/2022	Goldman Sachs Group Inc.	26,145	$66K	0.0%	+46.2%	0.041%
8/16/2022	Jane Street Group LLC	40,917	$0.10M	0.0%	N/A	0.065%
8/15/2022	State Street Corp	68,046	$0.17M	0.0%	-92.5%	0.108%
8/15/2022	Cubist Systematic Strategies LLC	11,470	$29K	0.0%	N/A	0.018%
8/15/2022	Citadel Advisors LLC	65,252	$0.16M	0.0%	N/A	0.103%
8/15/2022	Millennium Management LLC	246,054	$0.62M	0.0%	N/A	0.389%
8/12/2022	Northern Trust Corp	36,104	$91K	0.0%	-79.8%	0.057%
8/12/2022	Ikarian Capital LLC	70,000	$0.18M	0.0%	-86.4%	0.111%
8/11/2022	UBS Group AG	22,411	$56K	0.0%	+113.0%	0.035%
8/11/2022	JPMorgan Chase & Co.	64,519	$0.16M	0.0%	+570.2%	0.102%
8/8/2022	Oppenheimer & Co. Inc.	32,026	$81K	0.0%	+27.2%	0.051%
6/7/2022	Bank of America Corp DE	63,277	$0.25M	0.0%	+52.1%	0.100%
5/16/2022	Goldman Sachs Group Inc.	17,883	$70K	0.0%	N/A	0.028%
5/16/2022	State Street Corp	903,885	$3.56M	0.0%	+2.3%	1.429%
5/16/2022	Morgan Jess S & Co. Inc.	87,250	$0.34M	0.3%	+193.3%	0.138%
5/16/2022	UBS Group AG	10,524	$41K	0.0%	-40.4%	0.017%
5/13/2022	Northern Trust Corp	178,326	$0.70M	0.0%	-4.3%	0.282%
5/13/2022	Charles Schwab Investment Management Inc.	164,309	$0.65M	0.0%	+23.5%	0.260%
5/13/2022	Vanguard Group Inc.	789,963	$3.11M	0.0%	-21.7%	1.249%
5/12/2022	BlackRock Inc.	1,131,161	$4.46M	0.0%	-1.3%	1.788%
5/11/2022	Veritable L.P.	20,000	$79K	0.0%	N/A	0.032%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	241,737	$0.95M	0.0%	-3.4%	0.382%
5/2/2022	Allspring Global Investments Holdings LLC	32,129	$0.13M	0.0%	N/A	0.051%
2/7/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	250,235	$1.11M	0.0%	N/A	0.402%
2/2/2022	Oppenheimer & Co. Inc.	22,214	$91K	0.0%	N/A	0.036%
11/15/2021	Penserra Capital Management LLC	5,154	$35K	0.0%	-35.9%	0.008%
11/12/2021	Laird Norton Trust Company LLC	268,581	$1.83M	0.2%	+7.6%	0.437%
11/12/2021	Geode Capital Management LLC	405,737	$2.77M	0.0%	+0.8%	0.660%
11/9/2021	Morgan Jess S & Co. Inc.	29,750	$0.20M	0.1%	N/A	0.048%
11/9/2021	BlackRock Inc.	1,065,726	$7.28M	0.0%	-9.5%	1.733%
11/9/2021	Soltis Investment Advisors LLC	218,920	$1.50M	0.2%	N/A	0.356%
11/4/2021	Deutsche Bank AG	11,284	$77K	0.0%	-16.9%	0.018%
11/2/2021	New York State Common Retirement Fund	12,560	$86K	0.0%	-35.9%	0.020%
8/17/2021	Boothbay Fund Management LLC	13,276	$0.15M	0.0%	-21.6%	0.022%
8/16/2021	California State Teachers Retirement System	31,590	$0.36M	0.0%	N/A	0.051%
8/16/2021	Pinz Capital Management LP	6,292	$71K	0.0%	N/A	0.010%
8/16/2021	Charles Schwab Investment Management Inc.	147,392	$1.66M	0.0%	+53.0%	0.240%
8/16/2021	State Street Corp	278,619	$3.13M	0.0%	N/A	0.453%
8/16/2021	Nuveen Asset Management LLC	54,870	$0.62M	0.0%	N/A	0.089%
8/13/2021	Northern Trust Corp	82,770	$0.93M	0.0%	+105.7%	0.135%
8/13/2021	Geode Capital Management LLC	402,395	$4.52M	0.0%	+82.6%	0.655%
8/13/2021	Vanguard Group Inc.	1,132,082	$12.73M	0.0%	+9.3%	1.844%
8/12/2021	Kepos Capital LP	550,000	$6.18M	0.5%	+175.0%	0.896%
8/12/2021	Penserra Capital Management LLC	8,043	$90K	0.0%	+37.7%	0.013%
8/12/2021	State of Wisconsin Investment Board	15,626	$0.18M	0.0%	N/A	0.025%
8/12/2021	Legal & General Group Plc	2,223	$25K	0.0%	N/A	0.004%
8/12/2021	JPMorgan Chase & Co.	8,785	$99K	0.0%	N/A	0.014%
8/12/2021	The Manufacturers Life Insurance Company	13,393	$0.15M	0.0%	N/A	0.022%
8/11/2021	Bank of New York Mellon Corp	57,228	$0.64M	0.0%	N/A	0.093%
8/11/2021	BlackRock Inc.	1,177,265	$13.23M	0.0%	+2,071.4%	1.918%
8/11/2021	Deutsche Bank AG	13,585	$0.15M	0.0%	N/A	0.022%
8/5/2021	Rhumbline Advisers	15,031	$0.17M	0.0%	N/A	0.024%
8/2/2021	New York State Common Retirement Fund	19,600	$0.22M	0.0%	N/A	0.032%
8/2/2021	SRS Capital Advisors Inc.	52,250	$0.59M	0.1%	N/A	0.085%
8/2/2021	Advisor Group Holdings Inc.	5,000	$56K	0.0%	N/A	0.008%
5/19/2021	Squarepoint Ops LLC	30,676	$0.39M	0.0%	N/A	0.051%
5/18/2021	Millennium Management LLC	130,068	$1.66M	0.0%	N/A	0.218%
5/18/2021	Citadel Advisors LLC	46,163	$0.59M	0.0%	N/A	0.077%
5/17/2021	Ikarian Capital LLC	118,533	$1.52M	0.1%	N/A	0.199%
5/17/2021	Goldman Sachs Group Inc.	13,593	$0.17M	0.0%	N/A	0.023%
5/13/2021	Laird Norton Trust Company LLC	249,561	$3.19M	0.4%	N/A	0.419%
5/13/2021	Penserra Capital Management LLC	5,840	$74K	0.0%	N/A	0.010%
5/13/2021	Kepos Capital LP	200,000	$2.56M	0.2%	-24.0%	0.336%
5/13/2021	Citigroup Inc.	10,646	$0.14M	0.0%	N/A	0.018%
5/12/2021	Northern Trust Corp	40,246	$0.51M	0.0%	N/A	0.068%
5/12/2021	Geode Capital Management LLC	220,355	$2.82M	0.0%	N/A	0.370%
5/7/2021	BlackRock Inc.	54,217	$0.69M	0.0%	N/A	0.091%
4/27/2021	Harel Insurance Investments & Financial Services Ltd.	34,911	$1.49M	0.0%	N/A	1.010%
2/16/2021	Walleye Trading LLC	15,909	$0.14M	0.0%	N/A	0.460%
2/12/2021	Basso Capital Management L.P.	3,239	$29K	0.0%	N/A	0.094%
2/12/2021	Kepos Capital LP	263,235	$2.37M	0.2%	N/A	7.617%
2/10/2021	Bluefin Capital Management LLC	15,378	$0.14M	0.0%	N/A	0.445%

Data available starting January 2016

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Today's Range

Now: $1.59

$1.59

$1.67

50 Day Range

MA: $1.18

$0.95

$1.62

52 Week Range

Now: $1.59

$0.87

$5.13

Volume

144,847 shs

Average Volume

164,712 shs

Market Capitalization

$117.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of Clene?: Clene's top insider shareholders include:
General Resonance Llc (Major Shareholder)
David J Matlin (Director)
John Henry Stevens (Director)
Jonathon Gay (Director)
Robert Dee Etherington (CEO)
Alison Mosca (Director)
David J Matlin (Director)
Robert Glanzman (Insider)
Learn More about top insider investors at Clene.
Who are the major institutional investors of Clene?: Clene's top institutional shareholders include:
Simplex Trading LLC — 0.00%
FNY Investment Advisers LLC — 0.00%
Learn More about top institutional investors of Clene stock.
Which institutional investors are selling Clene stock?: Within the last quarter, CLNN stock was sold by these institutional investors:
Simplex Trading LLC
FNY Investment Advisers LLC
Within the last year, company insiders that have sold Clene company stock include:
General Resonance Llc (Major Shareholder)
David J Matlin (Director)
John Henry Stevens (Director)
Learn More investors selling Clene stock.